Having been committed to monoclonal antibody development for decades of years, Creative Biolabs has provided over 50,000 products and various services to global scientific research units every year, which brings us to be the first-class biotech company in this field. Increasing researches indicate that not only IgG monoclonal antibodies but also non-IgG isotype antibodies (IgA, IgM, IgE) perform an excellent therapeutic effect in both basic researches and clinical applications. To follow the trend of immunotherapy, our Ph.D. scientists have established a series of platforms for non-IgG antibody development based on our seasoned IgG antibody technologies. Our non-IgG therapeutic antibodies platforms extensively including but not limited to the followings:
Antibody GlycoOpitimize Platform
As antibody glycosylation shows a great impact on binding sites, affinity, half-life, and stability, and thereby the biological activities and efficiency of the therapeutic antibodies. Moreover, post-translational glycosylation varies between different antibody isotypes and sub-isotypes. Our Antibody GlycoOpitimize Platform can provide comprehensive, customized antibodies services for all isotypes and sub-isotypes.
Expression System Platform
Our antibody expression system mainly consists of two main categories, one is normal expression systems for antibody (IgG, IgA, IgM) production and the other is exclusive human glycol-engineered cell systems for large-scale recombinant antibodies production with post-translation modifications more similar to the natural endogenous human antibodies and the right patterns of glycosylation.
Features of Our Non-IgG Therapeutic Antibodies Platform
- Dedicated to non-IgG therapeutic antibody development for many years.
- One-stop service: covering custom antibody production to applications.
- Efficient: high-throughput, high accuracy, and specificity.
- Abundant experience and good reputation in the industry.
As a senior biotech company, Creative Biolabs has devoted to the field of antibody development for decades and established a series of comprehensive antibody platforms. Having won good reputations on IgG monoclonal antibody services, our new scientific research teams focus on non-therapeutic antibody development for several years. And now we are capable to provide a series of non-therapeutic antibodies products and services with high quality and competitive price. You can contact us or send us an inquiry for more detailed information.
!! For Research Use Only. Our products and services are NOT intended for diagnostic or therapeutic applications.